S&P 500Health Care· USA

BMY

Challenger

Bristol Myers Squibb

CHA

$58.06

-0.96%

Open $58.11·Prev $58.62

as of 13 Apr

CHALLENGER

Power Core

Bristol Myers Squibb's moat is its institutional capability in late-stage clinical development and global regulatory execution across multiple complex therapeutic areas simultaneously.

Published1 Apr 2026

UniverseS&P 500

SectorHealth Care

↑

Direction of Movement

In the Valley, With Outcome Still Undetermined

ROC 200

+22.5%